Among patients undergoing peripheral vascular surgery, less than 50% received antiplatelet therapy and only 13% received lipid-lowering therapy on discharge.
Cohort (n=52)
No
What is the rate of antiplatelet and lipid-lowering therapy use among patients undergoing peripheral vascular surgery?
52 patients undergoing peripheral vascular surgery
Antiplatelet and lipid-lowering therapy
Similar population of patients in Canada
Use of antiplatelet and lipid-lowering therapy on discharge
The study highlights suboptimal use of guideline-directed antiplatelet and lipid-lowering therapies in patients undergoing peripheral vascular surgery.
OBJECTIVE: To investigate the use of antiplatelet and lipid lowering therapy among patients undergoing peripheral vascular surgery, and to compare their use with that reported among a similar population of patients in Canada. METHODS: Chart review of a cohort of 52 patients undergoing peripheral vascular surgery. The study was carried out at King Fahad National Guard Hospital, Kingdom of Saudi Arabia in May 2000. RESULTS: On discharge, less than 50% of the patients received any antiplatelet or antithrombotic medication. Only 13% of the patients received lipid-lowering therapy. Those findings parallel those of Canadian publications. CONCLUSION: Current literature supports the use of anti platelet and lipid-lowering therapy among patients with peripheral vascular disease. In King Fahad Hopsital, National Guard, Kingdom of Saudi Arabia, the use of those beneficial interventions is likely sub-optimal. Factors other than randomized clinical trail derived evidence likely influence practice and behavior. Whether dissemination of evidence may change such a pattern of behavior requires further study.
Building similarity graph...
Analyzing shared references across papers
Loading...
Abdulaziz S. Aldawood
King Fahad Hospital Jeddah
Roman Jaeschke
Saudi Medical Journal
National Guard Health Affairs
King Fahad Hospital Jeddah
Building similarity graph...
Analyzing shared references across papers
Loading...
Aldawood et al. (Wed,) conducted a cohort in Peripheral vascular disease (n=52). Antiplatelet and lipid lowering therapy vs. Canadian population (literature) was evaluated on Use of antiplatelet and lipid lowering therapy on discharge. Among patients undergoing peripheral vascular surgery, less than 50% received antiplatelet therapy and only 13% received lipid-lowering therapy on discharge.
synapsesocial.com/papers/69dc87ea3afacbeac03e9ee8 — DOI: https://doi.org/10.15537/1658-3175.1711